康冠科技(001308.SZ):目前創新類顯示產品智能美粧鏡應用到汽車上已有進展
格隆匯1月16日丨康冠科技(001308.SZ)在接待機構投資者調研時表示,公司已於2023年6月成立惠州市康冠汽車電子有限公司,為公司全資子公司,公司欲佈局領域為智慧座艙、汽車配件的製造、銷售及創新應用等。目前創新類顯示產品智能美粧鏡應用到汽車上已有進展,公司近期取得一項名為“一種汽車遮陽板”的專利,整體上將鏡面功能與觸摸顯示的功能結合一體,可運用於公司鏡面顯示產品,使該類產品的功能更豐富,體驗感更佳,能夠滿足大眾多樣化的功能需求。該產品已成功中標某全球知名高端汽車品牌合作開發項目,當前處於驗證階段,具體量產時間待定。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.